Matthew Keller
Stock Analyst at H.C. Wainwright
(0.07)
# 4,497
Out of 4,534 analysts
87
Total ratings
22.1%
Success rate
-22.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Keller
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MCRB Seres Therapeutics | Reiterated: Buy | $12 | $5.33 | +125.14% | 2 | Jul 8, 2026 | |
| GALT Galectin Therapeutics | Reiterated: Buy | $11 | $4.18 | +163.47% | 10 | Jun 23, 2026 | |
| SXTP 60 Degrees Pharmaceuticals | Downgraded: Hold | n/a | $1.51 | - | 5 | May 20, 2026 | |
| GRI GRI Bio | Reiterated: Buy | $10 | $1.50 | +566.67% | 9 | May 14, 2026 | |
| KYNB Kyntra Bio | Reiterated: Buy | $43 | $7.23 | +494.74% | 13 | May 12, 2026 | |
| IFRX InflaRx | Rated: Buy | $6 → $8 | $1.86 | +331.27% | 10 | May 12, 2026 | |
| ACXP Acurx Pharmaceuticals | Reiterated: Buy | $31 | $1.55 | +1,900.00% | 10 | May 12, 2026 | |
| PHIO Phio Pharmaceuticals | Reiterated: Buy | $14 | $1.03 | +1,259.22% | 9 | May 8, 2026 | |
| GYRE Gyre Therapeutics | Reiterated: Buy | $18 | $6.05 | +197.52% | 10 | May 7, 2026 | |
| ITRMF Iterum Therapeutics plc | Downgraded: Hold | n/a | $0.027 | - | 5 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $25.87 | - | 4 | Oct 30, 2025 |
Seres Therapeutics
Jul 8, 2026
Reiterated: Buy
Price Target: $12
Current: $5.33
Upside: +125.14%
Galectin Therapeutics
Jun 23, 2026
Reiterated: Buy
Price Target: $11
Current: $4.18
Upside: +163.47%
60 Degrees Pharmaceuticals
May 20, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.51
Upside: -
GRI Bio
May 14, 2026
Reiterated: Buy
Price Target: $10
Current: $1.50
Upside: +566.67%
Kyntra Bio
May 12, 2026
Reiterated: Buy
Price Target: $43
Current: $7.23
Upside: +494.74%
InflaRx
May 12, 2026
Rated: Buy
Price Target: $6 → $8
Current: $1.86
Upside: +331.27%
Acurx Pharmaceuticals
May 12, 2026
Reiterated: Buy
Price Target: $31
Current: $1.55
Upside: +1,900.00%
Phio Pharmaceuticals
May 8, 2026
Reiterated: Buy
Price Target: $14
Current: $1.03
Upside: +1,259.22%
Gyre Therapeutics
May 7, 2026
Reiterated: Buy
Price Target: $18
Current: $6.05
Upside: +197.52%
Iterum Therapeutics plc
Mar 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.027
Upside: -
Oct 30, 2025
Downgraded: Hold
Price Target: n/a
Current: $25.87
Upside: -